Back to search

Article

Systematic identification of cancer-specific MHC-binding peptides with RAVEN

2017-09-24

Abstract excerpt

<h4>ABSTRACT</h4> Immunotherapy can revolutionize anti-cancer therapy if specific targets are available. Recurrent somatic mutations in the exome can create highly specific neo-antigens. However, especially pediatric cancers are oligo-mutated and hardly exhibit recurrent neo-antigens. Yet, immunogenic peptides encoded by cancer-specific genes (CSGs), which are virtually not expressed in normal tissues, may enable...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3ea08e12-e8e1-5f56-9e65-432970f8787d
DOI
10.1101/193276
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systematic identification of cancer-specific MHC-binding peptides with RAVENDOI 10.1101/193276
Select a neighboring publication to make it the new centre.